High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays

被引:31
作者
Carr, Jane
Bown, Nick P.
Case, Marian C.
Hall, Andrew G.
Lunec, John
Tweddle, Deborah A.
机构
[1] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
关键词
D O I
10.1016/j.cancergencyto.2006.08.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genomic copy number changes are detectable in many malignancies, including neuroblastoma. using techniques such as comparative genomic hybridization (CGH), microsatellite analysis, conventional karyotyping, and fluorescence in situ hybridization (FISH). We report the use of 10K single nucleotide polymorphism (SNP) microarrays to detect copy number changes and allelic imbalance in six neuroblastoma cell lines (IMR32, SHER NBL-S, SJNB-1, LS, and SKNBE2c). SNP data were generated using the GeneChip DNA Analysis and GeneChip chromosome copy number software (Affymetrix). SNP arrays confirmed the presence of all previously reported cytogenetic abnormalities in the cell lines, including chromosome I p deletion. MYCN amplification, pin of 17q and 11q, and 14q deletions. In addition, the SNP arrays revealed several chromosome gains and losses not detected by CGH or karyotyping; these included am of 8q21.1-24.3 and gain of chromosome 12 in IMR-32 cells;, loss at 4p15.3-16.1 and loss at 16p12.3-13.2 11q loss with loss of heterozygosity (LOH) at 11q14.3-23.3 in SJNB-1 cells; and loss at 8p21.2-23.3 and 9p21.3-22.1 with corresponding LOH in SHEP cells. The SNP arrays refined the mapping of the 2p amplicons in LS, BE2c, and IMR-32 cell lines, the 12q amplicon in LS cells, and also identified an 11q13 amplicon in LS cells. There was,good concordance among SNP arrays, CGH, and karyotyping. SNP array analysis is a powerful too[ for the detection of allelic imbalance in neuroblastoma and also allows identification of LOH without changes ill COPY number (uniparental disomy). (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 138
页数:12
相关论文
共 53 条
  • [1] Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines
    Ambros, PF
    Ambros, IM
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (06): : 492 - 504
  • [2] Genomic heterogeneity and instability in colorectal cancer: spectral karyotyping, glutathione transferase-M1 and ras
    Bartos, JD
    Stoler, DL
    Matsui, S
    Swede, H
    Willmott, LJ
    Sait, SN
    Petrelli, NJ
    Anderson, GR
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 568 (02) : 283 - 292
  • [3] Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization
    Beheshti, B
    Braude, I
    Marrano, P
    Thorner, P
    Zielenska, M
    Squire, JA
    [J]. NEOPLASIA, 2003, 5 (01): : 53 - 62
  • [4] Berner JM, 1996, GENE CHROMOSOME CANC, V17, P254, DOI 10.1002/(SICI)1098-2264(199612)17:4<254::AID-GCC7>3.0.CO
  • [5] 2-2
  • [6] BIEDLER JL, 1978, CANCER RES, V38, P3751
  • [7] Neuroblastoma tumour genetics: clinical and biological aspects
    Bown, N
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (12) : 897 - 910
  • [8] Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma
    Bown, N
    Cotterill, S
    Lastowska, M
    O'Neill, S
    Pearson, ADJ
    Plantaz, D
    Meddeb, M
    Danglot, G
    Brinkschmidt, C
    Christiansen, H
    Laureys, G
    Speleman, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) : 1954 - 1961
  • [9] Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
    Caron, H
    vanSluis, P
    deKraker, J
    Bokkerink, J
    Egeler, M
    Laureys, G
    Slater, R
    Westerveld, A
    Voute, PA
    Versteeg, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) : 225 - 230
  • [10] Carson-Walter EB, 2001, CANCER RES, V61, P6649